Clinical trial
Chelation Therapy of Iron Overload With Pyridoxal Isonicotinoyl Hydrazone
NCT00000588 · Case Western Reserve University, Other · Completed
Key facts
| NCT number | NCT00000588 |
|---|---|
| Title | Chelation Therapy of Iron Overload With Pyridoxal Isonicotinoyl Hydrazone |
| Official title | Chelation Therapy of Iron Overload With Oral Pyridoxal Isonicotinoyl Hydrazone |
| Lead sponsor | Case Western Reserve University, Other |
| Collaborators | National Heart, Lung, and Blood Institute (NHLBI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Anemia (Iron-Loading), Beta-Thalassemia, Hematologic Diseases, Hemoglobinopathies, Thalassemia, Iron Overload |
| Intervention type | Drug, Other |
| Interventions | Chelation therapy, Placebo |
| Enrollment | 120 |
| Start date | Jun 5, 1989 |
| Primary completion | Mar 31, 1993 |
| Completion | Mar 31, 1995 |
| First posted | Oct 28, 1999 |
| Last update posted | Sep 21, 2022 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: